| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 5.627 | 24.769 | 23.112 | 27.478 | 44.302 | 46.662 | 50.042 |
| Total Income - EUR | - | - | - | 5.627 | 24.769 | 23.213 | 27.577 | 44.302 | 47.247 | 50.042 |
| Total Expenses - EUR | - | - | - | 2.621 | 8.042 | 4.376 | 6.053 | 6.493 | 22.728 | 35.400 |
| Gross Profit/Loss - EUR | - | - | - | 3.006 | 16.726 | 18.837 | 21.524 | 37.809 | 24.519 | 14.642 |
| Net Profit/Loss - EUR | - | - | - | 2.837 | 15.983 | 18.142 | 20.700 | 36.507 | 20.618 | 11.445 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Empiricus Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 22.549 | 20.511 | 20.529 | 76.231 | 63.170 |
| Current Assets | - | - | - | 3.395 | 19.034 | 6.205 | 19.795 | 51.411 | 4.546 | 18.871 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 259 | 0 |
| Receivables | - | - | - | 889 | 3.073 | 630 | 1.424 | 2.183 | 1.823 | 8.429 |
| Cash | - | - | - | 2.506 | 15.961 | 5.576 | 18.370 | 49.228 | 2.465 | 10.442 |
| Shareholders Funds | - | - | - | 2.880 | 18.807 | 28.323 | 39.883 | 36.555 | 46.076 | 50.708 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 516 | 227 | 432 | 423 | 35.384 | 34.702 | 31.332 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Empiricus Medical S.r.l.